<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 179 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page178.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=179">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 179 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 179</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=179"><img src="../thumb/179.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>146 / 2020-04                                                   Blood and Haemopoeitic - 8.6 / 8.7 / 8.8
   pts.with norm./low BP, gen.tonoclon.seiz., headache, shunt throm-  admin. Infus: 1 amp.dilut.in 100 ml NaCl/2 amps dil. in 200 ml NaCl if   effs.with.15  mins.of compl.test dos. Elev. pt.arm & apply press.to
   bos.esp.in pts.with tenden. to hypotens./whose arterioven.fistulae   used.1  25 ml of sol.must be admin.as the test dos.   admin.site for at least 5 mins.prevent.paraven.leak.
                                   st
   exhibit complicat., fall in ser.Fe paramet., allerg.skin reacts., loc.  IV inj: Admin.slow.at rate of 1 ml undilut.sol./min. not exceed. 2 amps   Dos.calculat: Adults incl elderly: Tot.cumulativ. dos.determ.by
   reacts., anaphylact.reacts., flu-like sympts. partic.at start of ther.,   (200 mg Fe)/inj. Test dos of 1 ml(20 mg Fe) to be inj.over 1-2 mins.  Hb lev.& bm. Indiv.dos.& dos. sched. based on tot.iron defic. See
   neutral.anti-erythropoietin antibod.mediated PRCA, incr.ser.K &   bef.slow IV inj. Bal.of inj.may be giv.aft.15 mins.if no adverse react.  prod.lit.for calc. of tot.iron defic., numb.of vials admin.& dilut. criter.
   phosph.bld. lev., dos.depend.rise in platel.count,  Adults incl.elderly: Tot.cumulat.dos.determ.by Hb lev.& bm. Indiv.  Norm.recomm.dos.sched: 100 mg iron (1x5 ml vial) admin.not
   Warnings and special precautions: Refract. anaem. with excess   dos.& dos.sched. See prod.lit.for calc.of tot.Fe defic., numb.of amps.  more than 3x/wk. May be incr.to 200 mg iron (2x 5 ml vial) not
   blast in transformat., epilep., thrombocytos., chron.liv.fail., hypers-  to be admin.& dilut.criter. Norm.recomm.dos.sched.is 100 mg Fe (1x   more than 3x/wk.
                                                                        st
   ens., rule out folic acid & vit.B12 defic.as effectiven.of ther. reduc.,   5 ml amp.) not more than 3x/wk. When rapid deliv.of Fe to body   Contra-indications: 1  trimest.of pregn., safety in childr./lactat./
   abuse by healthy indiv.may incr.pack. cell vol. excess.with poss.life-  stores reqd.dos.may be incr.to 200 mg Fe admin.not more than 3x/  porphyr.not est., disturbs.in iron utilisat.or Fe overload, evid.hepat.
   threaten.CV complicat., phenylketonur., eval.Fe status prior to/dur   wk. Admin.to be split if tot.necess.dos.exceed.max.allow.sngl. dos  damage, infect. hepatit., ac./chron.infect., anaphylact./ allerg. react.
   ther.& supplement.ther.institut.where necess., condits. compromis.  Contraindications: Fe overload/Fe utilisat. disturbs. (e.g. haemo-  hist., anaem.not caus.by Fe defic., SC/IM admin.
   effectiven.incl. Fe defic./chron. inflamm./ chron.bld.loss/bone marr.  chromatos., haemosideros.), evid.hepat.damage, infectious hep-  Side-effects: Anaphylact./anaphylactoid/skin reacts., headache,
   fibros./sev.Al overload/folic acid & vit.B12 defic./haemolys., consid.   atit., ac./chron. infects., asthma/eczema/anaphylact./allerg.react.   dizzin., confus., reduc. consciousn. lev., lightheadn., paraesthes.,
   exam.of bone marr.for diagnos.of PRCA in sudd. drop of Hb assoc.   hist., anaem.not caus.by Fe defic., 1  trimest.of pregn., safety in   tachycard., palpitat., hypotens.& collapse, periph. oed., bronchosp.,
                                                st
   with reticulocytop. & anti-erythropoiet. antibod.where other po-  lactat./childr.not est.  angioed., dyspn., GI disturbs., musc. cramps/pain, joint swell., back
   tent.caus. excl., discont.& switch to other ESA if PRCA diagnos.,   Side effects: Anaphylact./anaphylactoid reacts., pneum., bld.dys-  pain, arthralg., metall.taste, fev., shiver., chest pain & tightn., flush.,
   monit.platelet counts/ haematocrit/Hb levs. at reg.interv.in all pts,   cras.incl.polycythem., angioed., Fe overload, CNS effs., dysgeus.,   fatig., asthen., malaise, hyperhidros., inj.site disords.
   do not switch pts.with confirm. neutralis.antibodies to erythropoi-  headache, dizzin., migraine, lightheadedn., anx., trem., tachycard.,   Special precautions: Use for approv.indic.only., not suit.for tot.dos.
   etin, poss. stimulat.of any malign.type, reg.BP monit. dur. dialys.&   palpitat., chest pain/tightn., hypotens.., collapse, periph. oed.,   infus., hypotens.episod.poss.if admin.too rapid., pts.with low bind.
   esp.start of ther., sudd.stabb. migraine-like headaches poss.warn.  flush., phlebit., admin.site reacts., shock, MI, dysrhythm., brady-  capacity &/ folic acid defic.at incr.risk of allerg./anaphylact. reacts.,
   sign.of hypertens. cris., poss. hepar.dos.adjustm. dur. haemodialys.,   card., hypertens., bronchosp., dyspn., GI disturbs., skin reacts.,   avoid paraven.leak.at inj.site, only use in pregn.women with sev.iron
   sev.Al overload may comprom. effectiven., occlus.of dialys.syst.  musc./ back/extremit. pain, myalg., joint swell., arthralg., limb   defic.anaem.where an inabil.to absorb/tol.adeq.amnts.of oral iron,
   if heparinisat.is not optim., monit.platel.count reg.dur.1 8 wks.of   discomf., musc.spasm, hypoton., chromatur., haematur., metall.  discont. oral Fe preps.bef.init.inj., stop ther.in case of mild allerg.re-
                           st
   treatm., discont.treatm.if platelet.incr.by more than 150x10 /l or   taste, burn., swell., shiver., fev., asthen., lymphadenopathy, hyper-  acts.& admin.antihistamin.
                             9
   above norm.range,for autolog.bld. donat. only pts.with PCV&gt;33%/  hidros., pallor, malaise.  Warnings: Resuscit.facilit.always to be avail.for poss.sev. allerg./
   care with pts. &lt;50 kg/ sngl.vol.withdr.not exceed.12% of pts.est.   Warnings and special precautions: Use for approv.indic.only,   anaphylact.reacts., discont.ther. in event of sev.allerg.react.and init.
   bld.vol., reserve treatm.for pts.where import.to avoid homolog.bld.   emergency facilit.to be avail., incr. hypersens.risk in known allerg.   est.resuscit. proced.
   transfus.consid.risk:benef.for homolog transfus., monit.K ser.lev.reg.  incl.meds./ sev. asthma hist./eczema or other atop.allerg./ immune   Drug interactions: Reduc.absorpt.of oral Fe preps.
   in chron. kidn. dis.& discont.if K lev.elev/ris., paed.use, poss. slight   or inflamm.condits., discont.ther.in case of mild allerg./anaphylact.
   rise in platelet counts particul up to day 12 - 14 of life in pts. treat.  reacts., hypotens. episod. if inj.admin.too rapidly, pts.with low Fe
   for anaem.of prematur.       bind. capacit.&/fol.acid defic.esp.at risk for allerg. react., avoid para- 8.7  Haemoglobin-Based
   REVOLADE, Novartis &         ven.leak.at admin.site, not admin. with concom.oral Fe preps., not
   Eltrombopag olamine          for SC/IM use/ tot.dos.infus., 200 mg max.dos.nev.to be exceed.  Oxygen Carrier
   Indications: Thrombocytopen.in adults with chron, idiopath.(im-  VENOFER, Takeda [P/S] &
   mune) thrombocytopen.purpura (ITP) where respons to corticoster./  Iron(III)-hydroxide sucrose complex equiv.to Fe.  HEMOPURE, OPK Biotech
   immunoglobul or splenectomy insuffic. Use only in pts.with ITP where   Indications: Sev.adult Fe defic.in pts.not tol./ respond. to oral   Polymerised haemoglobin of bovine origin in modif.lactat.Ringer’s sol.
   degree of thrombocytopen.& clinic.condit. incr.bleed.risk.  Fe.when confirm.by appropr. investigat.  Indications: Ac.anaem.adult surg.pts., elimin./ delay.or reduc.
   (S4) TABS, 44/26/0548, 0549  (S3) INJ, 32/8.3/0166. 100 mg/5 ml  need for allogen.RBC
   3000171-001: 25 mg, 28, R15 393,75  873276-019: 5x5 ml amps, R942,37  (S4) SOL FOR INFUS, 34/30.4/0261. 13 g/dL
   3000172-001: 50 mg, 28, R30 787,49  Dosage: IV admin.only by slow IV inj./IV drip infus/ into venous limb   700006-003: 250 ml (30 g), R13 000,00
   Dosage: Indiv.bas.on platel.counts, use low. effect. dos.regim.to   of dialyser in pts.receiv. haemodialys. Max. dly.dos.of 200 mg not to be   Dosage: Admin.using asept.techniq.through centr./ periph.vein. Rate
   maint.platel.counts as clin. indicat. May be tak.with food contain.  exceed. Do not mix with other meds for simultan. admin.0,9% NaCl is   of admin.1 g/min.guid. by clinic.condit.but may be admin.at high.rate
   little/pref.no Ca. Use only in pts.whose degr.of thrombocytopen. &   the only recomm. dil.for infus. Always admin.a test dos.of 20-50 mg   if necess. Cross match.with recipient bld.not necess.
   clinic.condit.incr.bleed.risk.  by chos.route to new pt bef. 1  therapeut. dos.If no adverse react.  Adults: Init.load.dos.60 g(2 units) follow.by period.infus.of 30-60 g
                                             st
   Adults: Recomm.start.dos: 50 mg once dly. Measurable elev.in   occurs aft.at least 15 min.admin. bal. of init.dos.(100 mg in at least   not exceed.tot.dos.of 210 g (7 units). Follow.init.load.dos.subseq. dos.
   platel.counts take 1-2 wks.   15 mins & 200 mg in at least 30 mins.)  should be 30 g guided by clinic.S&S of anaem.& body weight. As-
   Monit.& dos.adjustm: Adjust dos.to achieve/ maint. platel.count   Tot.cumulativ.dos.determ.by Hb lev.& bm. Indiv. dos. & dos.sched.   sess need for addit.admin.dly.as clinic.indicat. Discont.treatm.when
   ≥ 50 000/µl as necess.to reduc. bleed. risk. Ref.to prod.lit.for dos ad-  See prod.lit.for calc.of tot.Fe defic., numb.of amps.to be admin.&   haematocrit at least 18%.
   justm.guide. Monit.clin.haematol.& LFT reg., assess CBC incl. platel.   Contra-indications: Syst.mastocytos., uncontroll. hypertens.,
   count & periph.bld smears wkly.until stable platel.count (50 000/µl)   dilut. criteria.  not recomm.in pregn., safety in lactat.not est., insuffic.data for
                                Normal recomm.dos.sched.is 100 mg not more than 3x/wk. When
   achiev.then mnthly. thereaft. Do not exceed 75 mg dly. Wait.at least   use in childr.
   2 wks.aft.any dos.adjustm.prior to consider.another dos. adjustm.  rapid deliv.of Fe to body stores reqd.dos.may be incr.to 200 mg not   Side-effects: Abdom.pain, asthen., pain, hypertens., jaund., naus.,
                                more than 3x/wk.
   Discont.treatm.if platel.count not suffic.incr.to avoid clin.imp.bleed.  rash, haematur., CV events, fev., oed., CNS effs.incl.confus., post-op
   aft. 4 wks.at 75 mg once dly.  Contraindications: Fe overload/Fe utilisat. disturbs.   pain, decr.BP, GI disturbs., hypocalcaem./-kalaem /-magnesaem.,
   Contraindications: Safety in pregn./lactat.not est.  (e.g.haemochromatos, haemosideros.), anaem.not caus.by Fe defic.  resp.insuffic., rash, wound drain, diff.urinat., olig-/haematuria.,
   Side effects: Pharyngit., UTI, naus., diarrh., dry mouth, vomit., incr.   (e.g.haemolyt. anaem), clinic./biochemic.liv.damage evid., infect.   hypersens.reacts.
   aspartate/alanine aminotransfer., drug-induc.liv.inj., alopec., rash,   hepatit., ac/chron.infect., asthma/ eczema/other allerg.disords./  Special precautions: Pts.at risk of adverse effs. from fluid admin.,
                                               st
   back pain, musculoskelet.chest pain, musculoskelet.pain, myalg.  anaphylact.react. hist., safety in 1  trimest.pregn./lactat and childr   bld.transfus.not C/I in pts.receiv.treatm., do not infus./mix.with oth-
   Warnings and special precautions: Not for attempt.to normal.  not est., concom.oral Fe preps, IM/SC admin., total dos infus.(TDI),   er meds./fluids, red colour of ser./plasma samples which may af-
   platel.count., meas.ser. ALT/ AST/ bilirub.prior to init./every 2 wks.  not suit.for IM inj., safety in porphyr.not est.  fect clinic.lab.results, pulse oximetry values may decr.slightly, avoid
   dur. dos. adjustm. phase & mnthly follow.est.stable dos., eval.ab-  Side effects: Hypotens.& collapse, tachycard., palpitat., GI disturbs.,   circulat. overload esp.HF pts., other concom.colloid admin. to avoid
   norm.ser.liv.tests with repeat test.within 3-5 days. & if abnormalit.  abdom.pain, fev., shiver., flush., chest pain & tightn., loc.inj.site re-  overload, safety of more than 1 treatm.period of &lt; 6 days.not est.,
   confirm.monit.ser.liv.tests until resolv./stabilis./return.to baseline   acts., anaphylact.reacts.involv.arthralg., periph.oed., fatig., asthen.   discont. immed. if hypersens.react.occurs.
   lev., discont. if ALT lev.incr.(≥3x ULN) in pts.with norm.l iv. funct./≥3x   malaise, reduc.consciousn.lev., lighthead.feel., confus., angio-oed.,   Contact details: Tel: (012) 664-3994 OR
   baseline (or &gt;5x ULN, whichev.is low.) in pts.with elev.in transaminas.  joint swell., hyperhidros., back pain, musc.cramps, myalg., trans.  Mobile: 083 350-8808
   bef.treatm. that are progress./persist.for 2-4 wks./accomp.by incr.   taste pervers.partic.metall.taste, headache, dizzin., paraesthes.,
   direct bilirubin/accomp.by clin.sympts of liv. inj.or evid.for hepat.de-  bronchosp., dyspn., skin reacts.
   compensat., hepat. dis./ impairm., known risk fact.for thromboem-  Special precautions: Only admin.to pregn. women with sev.Fe   Others
                                defic.anaem.where there is an inability to absorb/tol.adeq.amnts of  8.8
   bol., monit. platel.count & consid.dos.reduct./discont.if platel.count
   exceeds targ.lev., monit.platel.count wkly.x 4 wks.follow.discont.as   oral Fe, driv.& mach.operat.not advis if pt.dizz./ confus./ light head.  NORMOSANG (MDR Listing)
   bleed.risk incr., incr. risk for dev./progress.of reticulin fibres within   Warnings: Resuscitat.facilit.always to be avail. for poss.allerg./
   bone marr., monit.pts.for cataracts at intervals &lt;6 mnths., consid.  anaphylact.reacts., discont. ther. in event of allerg.react.and init. est.   NORMOSANG, Equity [P/S] &
   dos.reduct.of concom.rosuvastatin, concom. OATP1B1 & BCRP   resuscitat.proced., pts.with low Fe bind. capacit. and/fol. acid defic.  Hemin
   substrat., monit.platel. count wkly for 2-3 wks.with init./discont.  partic.at risk of allerg. reacts.  Indications: Ac.hepat.porphyr.attacks.
   of concom. cyclosporin or lopinavir/ritonavir & adj. REVOLADE dos.  See also MDR page 706.  (S4) SOL, Z/34/19. 25 mg/ml
   accord., admin antacids/dairy prods. & other prods.contain.polyval.  ZYPIRON 20, Zydus [P/S]  847143-007: 4x10 ml amps, R38 563,50
   cations at least 4 hrs apart from REVOLADE, limit.data in pts. ≥ 65,   Iron sucrose equiv.to elemental iron.  Dosage: Start ther.without delay once est.that sympts.caus.by
   pts. of East Asian ancestry  Indications: Sev.adult Fe defic.in pts.not tol./ respond. to oral   porphyr. Dil.immed.bef.use, Admin.in large antebrach./centr.vein
   Interactions: C max & AUC of rosuvastatin incr, AUC & C max decr.  Fe.when confirm.by appropr. investigat.  using in-line filter over at least 30 mins. Rinse vein with 100 ml
   with polyval.cation-contain. antacids/ Ca-rich meals, incr. plasma   (S3) INJ, 45/8.3/0550. 20 mg/ml.  0,9% NaCl aft.infus.
   rosuvastatin expos., decr.expos.with cyclosporin, conc.decr. with   720231-001: 100 mg/5 ml, 5 vials, R620,11  Adults: Dly dos.3 mg/kg admin.as sngl.IV infus. gen.given for 4 days.
   lopinavir/ ritonavir         Dosage: IV admin.only. Infus.is pref.method of admin. Nev.exceed   May be prolong.in sev.cases but not for more than 1 wk.
   See also MDR page 565.       max.dos.of 200 mg. Admin. slow IV inj./IV drip infus.into venous   Contraindications: Safety in childr./pregn.& nurs. women not est.
                                                              Side effects: Infus.site reacts., anaphylact. reacts., hypersens., poor
   SUCROFER, Pharma Dynamics [P/S]  limb of dialyser in pts.receiv.haemodialys. Admin.a test dos.of 1 to   ven.access, pyrex., incr. ser.ferritin, col.of plasma, haemostas.disturbs.
                                                     st
   Iron sucrose equiv.to element.Fe.  2,5 ml Zypiron (20-50 mg iron) by chos. route bef. 1  therap.dos. Bal.  with high dos., decr.in coagulat.fact.IX & X paramet., poss. adverse
   Indications: Sev.adult Fe defic.in pts.not tol./ respond. to oral   of init.dos.may be giv.if no adverse react.occurs with.wait.per.of at   effs.on CNS due to high propylene glycol content lead.to lact.acidos./
   Fe.when confirm. by appropr. investigat.  least 15  min.aft.admin.  ren & hepat. toxic.& haemolyt.reacts.poss.harmf.in liv.dis./ alcohol./
   (S3) INJ, A45/8.3/0252. 20 mg/ml  Infus: 1 amp dilut.in 100 ml NaCl immed.prior to infus. (or 2 amps in   epilep./brain injury or dis./pregn.women & childr.
                                          st
   720333-001: 5x5 ml amps, R593,25  200 ml NaCl if used). 1  25 ml of sol.infus. as test dos.over 15 min.   Warnings and special precautions: Monit. body iron stores
   Dosage: Admin.IV only. Admin.test dos.to a new pt. of 1-2,5 ml Su-  Bal.of infus.to be giv.if no adverse react.dur.15 min.wait.per. Infus.   period.
                   st
   crofer (20-50 mg Fe) by chos. route bef.1  therap.dos. Bal.of init.dos.  rate to be no more than 50 ml in 15 min.  Drug interactions: Avoid concom.meds that incr.delta-aminolae-
   may be giv. if no adverse react.occurs aft.15 min.wait per. Infus. rate   IV inj: Admin.slow. at rate of 1 ml undilut.sol/min. not exceed.2 vials   vulinic acid synthase activ., ethanol content may modify/incr.eff.
   no more than 50 ml in 15 mins.by slow IV inj./IV drip infus./into ve-  (200 mg iron) per inj.1 ml (20 mg iron) test dos.to be inj.slow.over per.  of other meds.
   nous limb of dialyser in pts. receiv.haemodialys. Infus.pref.method of   of 1-2  mins. bef. slow IV inj. Bal.of init.dos.may be giv.if no adverse   See also MDR page 309.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page178.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page174.html">174</a>&nbsp;&nbsp;&nbsp;<a href="page175.html">175</a>&nbsp;&nbsp;&nbsp;<a href="page176.html">176</a>&nbsp;&nbsp;&nbsp;<a href="page177.html">177</a>&nbsp;&nbsp;&nbsp;<a href="page178.html">178</a>&nbsp;&nbsp;&nbsp;<a href="page179.html">179</a>&nbsp;&nbsp;&nbsp;<a href="page180.html">180</a>&nbsp;&nbsp;&nbsp;<a href="page181.html">181</a>&nbsp;&nbsp;&nbsp;<a href="page182.html">182</a>&nbsp;&nbsp;&nbsp;<a href="page183.html">183</a>&nbsp;&nbsp;&nbsp;<a href="page184.html">184</a>
             </td>
             <td width="35%"><a href="page180.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page180.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
